For Media: UK Press Releases

This page contains resources intended for journalists only. For media enquiries about our press releases please contact ukmediaenquiries@bayer.com

News context

News Area (field_news_area)

News Topic (field_news_topic)

Country

May 17, 2024

Elinzanetant significantly reduces frequency and severity of moderate to severe hot flushes associated with menopause in women

March 19, 2024

Positive topline results from Phase III long-term study

March 04, 2024

Bayer strengthens pharma CV portfolio with acoramidis

January 08, 2024

Bayer's elinzanetant meets all primary and key secondary endpoints in pivotal OASIS 1 and 2 Phase III studies

January 05, 2024

Mirena® (52mg levonorgestrel IUS) authorised in the UK for extended use up to eight years for contraception

November 01, 2023

Bayer UKI launches first digital patient support package in diabetic kidney disease

October 10, 2023

Bayer invests 250 million USD in new cell therapy manufacturing facility in the U.S.

October 09, 2023

Scottish Medicines Consortium (SMC) recommends two Bayer cancer treatments for use within NHSScotland